STAGE IV LUNG CANCER AJCC V8
Clinical trials for STAGE IV LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink Hard-to-Treat lung tumors
Disease control Not yet recruitingThis study tests two drugs, alone or together, for people with advanced non-small cell lung cancer that has specific gene changes (like EGFR or ALK) and has come back after prior treatment. The drugs are sacituzumab govitecan, which delivers a toxin directly to cancer cells, and …
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 26, 2026 07:02 UTC
-
New radiation drug aims to slow bone tumors in advanced cancer
Disease control Not yet recruitingThis early-phase study tests a new drug (Sn-117m-DTPA) that delivers low-level radiation directly to bone tumors while being gentler on bone marrow. It is for people with prostate, breast, or lung cancer that has spread to the bones. The main goals are to find the safest dose and…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:00 UTC
-
Light-Activated drug combo takes aim at Hard-to-Treat lung cancer
Disease control Not yet recruitingThis study tests a new combination treatment for people with advanced non-small cell lung cancer that has not responded to standard therapies. The treatment uses a light-activated drug (ASP-1929) plus an immunotherapy drug (cemiplimab) to target and kill cancer cells. About 27 ad…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 06:49 UTC
-
New hope for advanced lung cancer patients: drug combo aims to reawaken immune system
Disease control Not yet recruitingThis study tests a new two-drug combination (SX-682 and atezolizumab) for people with advanced non-small cell lung cancer whose cancer continued to grow after chemotherapy and immunotherapy. The goal is to see if the combination can shrink tumors or slow the disease. About 32 adu…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Spinal tap may predict brain metastases in lung cancer patients
Knowledge-focused Not yet recruitingThis study looks at whether a spinal tap (lumbar puncture) can find bits of tumor DNA in the fluid around the brain and spine. It includes 40 people with stage III or IV non-small cell lung cancer, who are at risk for the cancer spreading to the brain. The goal is to see if this …
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 07:02 UTC